GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eris Lifesciences Ltd (BOM:540596) » Definitions » Receivables Turnover

Eris Lifesciences (BOM:540596) Receivables Turnover : 1.38 (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Eris Lifesciences Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Eris Lifesciences's Revenue for the three months ended in Dec. 2023 was ₹4,835 Mil. Eris Lifesciences's average Accounts Receivable for the three months ended in Dec. 2023 was ₹3,497 Mil. Hence, Eris Lifesciences's Receivables Turnover for the three months ended in Dec. 2023 was 1.38.


Eris Lifesciences Receivables Turnover Historical Data

The historical data trend for Eris Lifesciences's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eris Lifesciences Receivables Turnover Chart

Eris Lifesciences Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.84 8.79 8.02 8.80 7.33

Eris Lifesciences Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.41 1.35 1.57 1.43 1.38

Competitive Comparison of Eris Lifesciences's Receivables Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Eris Lifesciences's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eris Lifesciences's Receivables Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eris Lifesciences's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Eris Lifesciences's Receivables Turnover falls into.



Eris Lifesciences Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Eris Lifesciences's Receivables Turnover for the fiscal year that ended in Mar. 2023 is calculated as

Receivables Turnover (A: Mar. 2023 )
=Revenue / Average Total Inventories
=Revenue (A: Mar. 2023 ) / ((Accounts Receivable (A: Mar. 2022 ) + Accounts Receivable (A: Mar. 2023 )) / count )
=16618.16 / ((1609.68 + 2927.09) / 2 )
=16618.16 / 2268.385
=7.33

Eris Lifesciences's Receivables Turnover for the quarter that ended in Dec. 2023 is calculated as

Receivables Turnover (Q: Dec. 2023 )
=Revenue / Average Total Inventories
=Revenue (Q: Dec. 2023 ) / ((Accounts Receivable (Q: Sep. 2023 ) + Accounts Receivable (Q: Dec. 2023 )) / count )
=4834.81 / ((3497.49 + 0) / 1 )
=4834.81 / 3497.49
=1.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eris Lifesciences  (BOM:540596) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Eris Lifesciences Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Eris Lifesciences's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Eris Lifesciences (BOM:540596) Business Description

Traded in Other Exchanges
Address
Ramdas Road, Plot No. 142/2, Shivarth Ambit, Off SBR, Near Swati Bungalows, Bodakdev, Ahmedabad, GJ, IND, 380054
Eris Lifesciences Ltd is an India-based company engaged in the manufacturing and sale of branded pharmaceutical formulations. It focuses on Lifestyle therapies such as Diabetes Care, Cardiac Care, Nutrition, Central Nervous System, and others. The company operates in a single segment that is pharmaceuticals. Some of its brands include Glimisave, Cyblex, Eritel, Atorsave and Crevast.

Eris Lifesciences (BOM:540596) Headlines

No Headlines